Literature DB >> 15736203

Perinatal management of right aortic arch with aberrant left subclavian artery associated with critical stenosis of the subclavian artery in a newborn.

E Tschirch1, R Chaoui, R R Wauer, M Schneider, M Rüdiger.   

Abstract

A right-sided aortic arch with an aberrant left subclavian artery is a congenital vascular anomaly that is easily detectable in utero at the level of the three vessels and trachea view, but which is rarely symptomatic in the neonate. We present a newborn with prenatally diagnosed right-sided aortic arch and aberrant subclavian artery who showed a clinically relevant stenosis of the subclavian artery during the first week of life. An intravascular stent was implanted into the stenosis of the aberrant left subclavian artery by catheterization. This case report demonstrates that a right-sided aortic arch with an aberrant subclavian artery can be diagnosed prenatally, that in these patients a stenosis of the subclavian artery can occur in early infancy and requires awareness of the neonatologist or pediatrician, and that stent implantation represents a minimally invasive therapeutic approach.

Entities:  

Mesh:

Year:  2005        PMID: 15736203     DOI: 10.1002/uog.1841

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  Perinatal outcomes and anomalies associated with fetal right aortic arch.

Authors:  Ahmet Gül; Kemal Güngördük; Gökhan Yıldırım
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

2.  Right aortic arch analysis - Anatomical variant or serious vascular defect?

Authors:  Agata Arazińska; Michał Polguj; Konrad Szymczyk; Magdalena Kaczmarska; Łukasz Trębiński; Ludomir Stefańczyk
Journal:  BMC Cardiovasc Disord       Date:  2017-04-19       Impact factor: 2.298

3.  The multiform sonographic spectrum of arterial duct in right aortic arch.

Authors:  Enrico Chiappa; Cecilia Ridolfi; Adalgisa Cordisco
Journal:  Int J Cardiovasc Imaging       Date:  2021-07-08       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.